Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ-Reference-Cited by-同舟云学术

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Published:2018-02-03 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Beguinot Marie,Dauplat Marie-Melanie,Kwiatkowski Fabrice,Lebouedec Guillaume,Tixier Lucie,Pomel Christophe,Penault-Llorca Frederique,Radosevic-Robin Nina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4013-6.pdf

Reference42 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

2. Hoffman AW, Ibarra-Drendall C, Espina V, Liotta L, Seewaldt V. Ductal carcinoma in situ: challenges, opportunities, and uncharted waters. Am Soc Clin Oncol Educ Book. 2012:40–4.

3. Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol. 2015;12(4):227–38.

4. Pang JM, Gorringe KL, Fox SB. Ductal carcinoma in situ - update on risk assessment and management. Histopathology. 2016;68(1):96–109.

5. Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, et al. Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci U S A. 2016;113(39):10750–8.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast;Breast Cancer Research and Treatment;2024-08-24

2. IL-7R Expression Correlates with Prognosis in Breast Cancer;Combinatorial Chemistry & High Throughput Screening;2024-04-17

3. Identification of a prognostic gene signature based on invasion-related genes in breast cancer;2024-01-02

4. Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer;Acta Oncologica;2023-11-14

5. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression;Cancers;2023-05-08